HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
HCA Healthcare, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$454.88−3.96 (-0.86%)
Close on Oct 19, 2026
- Market cap
- $103.10B
- P/E (TTM)
- 15.6
- Dividend yield
- 0.63%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
62.1%
135M of 217M shares
Institutional holders
1,337
123 new, 186 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 13 sales
Net sold $31.12M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Thomas F. Frist, Jr. | 70,555,590 | 31.60% | 13D (active) | Feb 6, 2026 |
| Hercules Holding II | 68,912,077 | 25.70% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 11,746,315 | 5.25% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HCA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,003,600 | 6.01% | $5.07B | −359,666 | 0.08% |
| Vanguard Capital Management LLC | 10,141,708 | 4.68% | $3.95B | −36,654 | 0.08% |
| Sanders Capital, LLC | 8,828,287 | 4.08% | $3.44B | −128,858 | 3.45% |
| State Street Corp | 7,469,035 | 3.45% | $2.91B | −70,515 | 0.09% |
| First Eagle Investment Management, LLC | 6,591,130 | 3.04% | $2.57B | +3,336,560 | 2.13% |
| Wellington Management Group Llp | 4,707,473 | 2.17% | $1.84B | +799,761 | 0.32% |
| Geode Capital Management, LLC | 3,668,008 | 1.69% | $1.42B | −24,505 | 0.08% |
| Vanguard Portfolio Management LLC | 2,712,828 | 1.25% | $1.06B | −44,951 | 0.05% |
| Morgan Stanley | 2,586,771 | 1.19% | $1.01B | +291,891 | 0.05% |
| Goldman Sachs Group Inc | 2,464,314 | 1.14% | $960.81M | +328,242 | 0.08% |
| JPMorgan Chase & Co | 2,285,832 | 1.06% | $896.80M | −176,143 | 0.05% |
| Arrowstreet Capital, Limited Partnership | 2,209,485 | 1.02% | $861.46M | +44,227 | 0.38% |
| Norges Bank | 2,145,367 | 0.99% | $836.46M | New | 0.08% |
| Capital World Investors | 1,977,121 | 0.91% | $770.86M | +4,692 | 0.09% |
| Capital International Investors | 1,916,947 | 0.89% | $747.40M | −1,116,665 | 0.15% |
| Northern Trust Corp | 1,708,560 | 0.79% | $666.15M | −43,567 | 0.08% |
| FMR LLC | 1,632,520 | 0.75% | $636.50M | −2,768,503 | 0.03% |
| Invesco Ltd. | 1,529,637 | 0.71% | $596.39M | +91,112 | 0.05% |
| Nordea Investment Management Ab | 1,429,943 | 0.66% | $553.70M | −17,606 | 0.45% |
| Barclays PLC | 1,319,216 | 0.61% | $514.35M | +70,901 | 0.10% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,337 | 135M | 62.1% | 123 / 446 | 572 / 186 | 17M | 13M |
| Q1 2026 | 1,423 | 131M | 60.7% | 151 / 491 | 562 / 105 | 25M | 15M |
| Q4 2025 | 1,397 | 137M | 63.3% | 213 / 473 | 522 / 87 | 12M | 15M |
| Q3 2025 | 1,289 | 140M | 64.7% | 135 / 447 | 494 / 79 | 8M | 16M |
| Q2 2025 | 1,250 | 148M | 68.4% | 143 / 444 | 470 / 99 | 8M | 15M |
| Q1 2025 | 1,226 | 155M | 71.7% | 166 / 436 | 452 / 103 | 13M | 14M |
| Q4 2024 | 1,180 | 159M | 73.5% | 148 / 396 | 471 / 150 | 12M | 13M |
| Q3 2024 | 1,204 | 160M | 74.1% | 148 / 404 | 462 / 86 | 22M | 13M |
| Q2 2024 | 1,156 | 166M | 76.8% | 114 / 455 | 409 / 72 | 8M | 12M |
| Q1 2024 | 1,126 | 171M | 79.1% | 154 / 362 | 421 / 67 | 9M | 10M |
| Q4 2023 | 1,057 | 173M | 80.1% | 154 / 334 | 423 / 86 | 15M | 10M |
| Q3 2023 | 1,001 | 169M | 77.9% | 106 / 360 | 370 / 110 | 9M | 14M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of HCA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 4,930,087 | 2.28% | $1.92B | 0.08% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 4,024,763 | 1.86% | $1.57B | 0.09% | Jun 30, 2026 |
| Growth Fund of America | 4,004,292 | 1.85% | $1.52B | 0.42% | May 31, 2026 |
| First Eagle Global Fund | 2,185,757 | 1.01% | $879.96M | 1.16% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 2,135,685 | 0.99% | $832.68M | 0.09% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 2,003,187 | 0.93% | $758.29M | 0.09% | May 31, 2026 |
| Vanguard Health Care Fund | 1,594,006 | 0.74% | $641.73M | 1.68% | Jul 31, 2026 |
| Vanguard Windsor Ii Fund | 1,528,930 | 0.71% | $615.53M | 0.92% | Jul 31, 2026 |
| Vanguard Value Index Fund | 1,477,267 | 0.68% | $575.97M | 0.23% | Jun 30, 2026 |
| Vanguard Wellington Fund | 1,329,214 | 0.61% | $503.16M | 0.40% | May 31, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,097,065 | 0.51% | $427.73M | 1.05% | Jun 30, 2026 |
| Pacer US Cash Cows 100 ETF | 960,711 | 0.44% | $386.77M | 2.07% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 842,999 | 0.39% | $328.68M | 0.09% | Jun 30, 2026 |
| T. Rowe Price Capital Appreciation Fund | 777,720 | 0.36% | $303.23M | 0.43% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 499,051 | 0.23% | $200.91M | 0.21% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Samuel N. Hazen | CEO, Director | 1,403,617 | 0.65% | Feb 12, 2026 |
| Michael J. Schlosser | EVP and Chief Clinical Officer | 7,121 | 0.00% | Sep 11, 2026 |
| Michael R. McAlevey | EVP & Chief Legal & Admin Off. | 10,990 | 0.01% | Aug 28, 2026 |
| Mike A. Marks | EVP and CFO | 73,076 | 0.03% | May 11, 2026 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 35,581 | 0.02% | Feb 12, 2026 |
| Christopher F. Wyatt | SVP & Controller | 44,379 | 0.02% | Feb 12, 2026 |
| Jon M. Foster | EVP and COO | 194,516 | 0.09% | Feb 12, 2026 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 16,003 | 0.01% | Feb 12, 2026 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10,825 | 0.00% | Feb 12, 2026 |
| Sammie S. Mosier | SVP & Chief Nurse Executive | 11,340 | 0.01% | Feb 18, 2025 |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 9,454 | 0.00% | Nov 18, 2024 |
| Phillip G. Billington | SVP-Internal Audit Services | 52,702 | 0.02% | Nov 14, 2024 |
| Erol R. Akdamar | Group President | 127,340 | 0.06% | Nov 14, 2024 |
| William R. Frist | Director, 10% owner | 69,256,716 | 31.99% | Apr 30, 2026 |
| Hugh F. Johnston | Director | 4,475 | 0.00% | Apr 30, 2026 |
| Nancy Ann Deparle | Director | 21,910 | 0.01% | Apr 30, 2026 |
| Michael W. Michelson | Director | 23,385,908 | 10.80% | Apr 30, 2026 |
| John Chidsey | Director | 1,333 | 0.00% | Apr 30, 2026 |
| Thomas F. Frist Iii | Director, 10% owner | 68,855,888 | 31.80% | Apr 30, 2026 |
| Wayne Joseph Riley | Director | 15,029 | 0.01% | Apr 30, 2026 |
| Andrea B. Smith | Director | 4,748 | 0.00% | Apr 30, 2026 |
| Robert J. Dennis | Director | 26,601 | 0.01% | May 1, 2025 |
| Patricia F. Elcan | 10% owner | 32,476,233 | 15.00% | Feb 10, 2026 |
| Holding Frisco II | 10% owner | 54,361,266 | 25.11% | Feb 10, 2026 |
| Holding Hercules Ii | 10% owner | 32,282,889 | 14.91% | Feb 10, 2026 |
| Thomas F. Frist Jr | 10% owner | 32,761,844 | 15.13% | Feb 10, 2026 |
| Of America Corp /De/ Bank | 10% owner | 0 | – | Mar 28, 2025 |
| Of America Na Bank | 10% owner | – | – | Mar 28, 2025 |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | 10% owner | – | – | Mar 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael R. McAlevey EVP & Chief Legal & Admin Off. | Aug 26, 2026 | Other | −7,769 | $429.00 | $3.33M | 0 |
| Mike A. Marks EVP and CFO | May 7, 2026 | Gift | +3,336 | – | – | 46,576 |
| Mike A. Marks EVP and CFO | May 7, 2026 | Gift | −3,336 | – | – | 0 |
| Andrea B. Smith Director | Apr 28, 2026 | Award | +509 | – | – | 4,666 |
| Michael W. Michelson Director | Apr 28, 2026 | Award | +925 | – | – | 12,576 |
| Thomas F. Frist Iii Director, 10% owner | Apr 28, 2026 | Award | +1,041 | – | – | 15,858 |
| Hugh F. Johnston Director | Apr 28, 2026 | Award | +809 | – | – | 4,475 |
| William R. Frist Director, 10% owner | Apr 28, 2026 | Award | +809 | – | – | 13,740 |
| Nancy Ann Deparle Director | Apr 28, 2026 | Award | +509 | – | – | 21,910 |
| Wayne Joseph Riley Director | Apr 28, 2026 | Award | +509 | – | – | 15,029 |
| John Chidsey Director | Apr 28, 2026 | Award | +809 | – | – | 1,305 |
| Michael R. McAlevey EVP & Chief Legal & Admin Off. | Feb 18, 2026 | Sale | −1,694 | $533.37 | $903.53K | 8,853 |
| Michael R. McAlevey EVP & Chief Legal & Admin Off. | Feb 13, 2026 | Option exercise | +5,000 | $236.61 | $1.18M | 13,853 |
| Michael R. McAlevey EVP & Chief Legal & Admin Off. | Feb 13, 2026 | Tax withholding | −3,306 | $540.29 | $1.79M | 10,547 |
| Jennifer Berres SVP & Chief Human Res. Officer | Feb 11, 2026 | Sale | −4,010 | $503.00 | $2.02M | 16,003 |
| Jennifer Berres SVP & Chief Human Res. Officer | Feb 11, 2026 | Sale | −4,010 | $526.16 | $2.11M | 11,993 |
| Christopher F. Wyatt SVP & Controller | Feb 11, 2026 | Sale | −4,000 | $505.00 | $2.02M | 44,379 |
| Michael R. McAlevey EVP & Chief Legal & Admin Off. | Feb 10, 2026 | Tax withholding | −3,006 | $502.05 | $1.51M | 8,853 |
| Michael R. McAlevey EVP & Chief Legal & Admin Off. | Feb 10, 2026 | Award | +8,372 | – | – | 11,859 |
| Jennifer Berres SVP & Chief Human Res. Officer | Feb 10, 2026 | Tax withholding | −2,515 | $502.05 | $1.26M | 20,013 |
| Jennifer Berres SVP & Chief Human Res. Officer | Feb 10, 2026 | Award | +7,116 | – | – | 22,528 |
| Mike A. Marks EVP and CFO | Feb 10, 2026 | Award | +5,026 | – | – | 5,026 |
| Mike A. Marks EVP and CFO | Feb 10, 2026 | Tax withholding | −1,690 | $502.05 | $848.46K | 3,336 |
| Erica Rossitto SVP & Chief Nurse Executive | Feb 10, 2026 | Award | +1,676 | – | – | 10,825 |
| Erica Rossitto SVP & Chief Nurse Executive | Feb 10, 2026 | Tax withholding | −418 | $502.05 | $209.86K | 10,407 |
| Christopher F. Wyatt SVP & Controller | Feb 10, 2026 | Tax withholding | −1,034 | $502.05 | $519.12K | 48,379 |
| Christopher F. Wyatt SVP & Controller | Feb 10, 2026 | Award | +3,350 | – | – | 49,413 |
| Samuel N. Hazen CEO, Director | Feb 10, 2026 | Award | +54,934 | – | – | 86,165 |
| Samuel N. Hazen CEO, Director | Feb 10, 2026 | Tax withholding | −21,323 | $502.05 | $10.71M | 64,842 |
| Jon M. Foster EVP and COO | Feb 10, 2026 | Tax withholding | −5,888 | $502.05 | $2.96M | 23,062 |
| Jon M. Foster EVP and COO | Feb 10, 2026 | Award | +15,696 | – | – | 28,950 |
| Michael S. Cuffe EVP and Chief Clinical Officer | Feb 10, 2026 | Award | +9,628 | – | – | 35,581 |
| Michael S. Cuffe EVP and Chief Clinical Officer | Feb 10, 2026 | Tax withholding | −3,501 | $502.05 | $1.76M | 32,080 |
| Holding Frisco II 10% owner | Feb 6, 2026 | Other | +36,557,141 | – | – | 36,557,141 |
| Holding Frisco II 10% owner | Feb 6, 2026 | Other | −36,629,188 | – | – | 0 |
| Holding Hercules Ii 10% owner | Feb 6, 2026 | Other | −36,629,188 | – | – | 32,282,889 |
| Patricia F. Elcan 10% owner | Feb 6, 2026 | Other | −36,629,188 | – | – | 0 |
| Patricia F. Elcan 10% owner | Feb 6, 2026 | Other | +36,557,141 | – | – | 36,557,141 |
| William R. Frist Director, 10% owner | Feb 6, 2026 | Other | +36,557,141 | – | – | 36,557,141 |
| William R. Frist Director, 10% owner | Feb 6, 2026 | Other | −36,629,188 | – | – | 0 |
| Thomas F. Frist Jr 10% owner | Feb 6, 2026 | Other | −36,629,188 | – | – | 0 |
| Thomas F. Frist Jr 10% owner | Feb 6, 2026 | Other | +36,557,141 | – | – | 36,557,141 |
| Thomas F. Frist Iii Director, 10% owner | Feb 6, 2026 | Other | +36,557,141 | – | – | 36,557,141 |
| Thomas F. Frist Iii Director, 10% owner | Feb 6, 2026 | Other | −36,629,188 | – | – | 0 |
| Jon M. Foster EVP and COO | Feb 5, 2026 | Tax withholding | −16,076 | $513.76 | $8.26M | 13,254 |
| Jon M. Foster EVP and COO | Feb 5, 2026 | Option exercise | +29,330 | $139.06 | $4.08M | 29,330 |
| Christopher F. Wyatt SVP & Controller | Feb 5, 2026 | Option exercise | +10,670 | $139.06 | $1.48M | 51,737 |
| Christopher F. Wyatt SVP & Controller | Feb 5, 2026 | Tax withholding | −5,674 | $513.76 | $2.92M | 46,063 |
| Samuel N. Hazen CEO, Director | Feb 4, 2026 | Other | −1,045 | $498.35 | $520.78K | 31,231 |
| Samuel N. Hazen CEO, Director | Feb 4, 2026 | Other | +1,045 | $498.35 | $520.78K | 16,024 |
| Michael S. Cuffe EVP and Chief Clinical Officer | Feb 3, 2026 | Sale | −1,500 | $498.09 | $747.14K | 30,003 |
| Michael S. Cuffe EVP and Chief Clinical Officer | Feb 3, 2026 | Gift | −4,050 | – | – | 25,953 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −120 | $497.18 | $59.66K | 32,276 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −4,293 | $498.12 | $2.14M | 32,396 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −5,162 | $498.80 | $2.57M | 36,689 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −6,189 | $500.02 | $3.09M | 41,851 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −7,395 | $500.69 | $3.70M | 48,040 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −5,002 | $502.15 | $2.51M | 55,435 |
| Samuel N. Hazen CEO, Director | Feb 3, 2026 | Sale | −14,716 | $502.95 | $7.40M | 60,437 |
| Samuel N. Hazen CEO, Director | Jan 30, 2026 | Tax withholding | −41,483 | $488.27 | $20.25M | 75,153 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| R. McAlevey Michael OFFICER | Feb 18, 2026 | 1,694 | $903.49K | Feb 18, 2026 | Exercise of a Stock Appreciation Right |
| L. Berres Jennifer OFFICER | Feb 11, 2026 | 8,020 | $4.13M | Feb 11, 2026 | Vesting of a Stock Award |
| N. Hazen Samuel President, Chief Executive Officer & Director | Feb 3, 2026 | 42,877 | $21.48M | Feb 3, 2026 | Exercise of a Stock Appreciation Right |
| S. Cuffe Michael OFFICER | Feb 3, 2026 | 1,500 | $747.14K | Feb 3, 2026 | Exercise of a Stock Appreciation Right |
| R. McAlevey Michael OFFICER | Nov 5, 2025 | 3,892 | $1.84M | Nov 5, 2025 | Exercise of a Stock Appreciation Right |
| Michael S. Cuffe Officer | Sep 8, 2025 | 3,836 | $1.61M | Sep 8, 2025 | EXERCISE OF STOCK APPRECIATION RIGHT |
| Jon M. Foster Officer | May 13, 2025 | 15,698 | $5.80M | May 13, 2025 | Exercise of a Stock Award |
| Jennifer Berres Officer | Feb 14, 2025 | 9,533 | $3.08M | Feb 14, 2025 | Vesting of a Stock Award |
| Deborah M. Reiner Former Officer | Feb 11, 2025 | 3,510 | $1.13M | Feb 11, 2025 | Vesting of a Stock Award |
| Kathleen M. Whalen Former Officer | Jan 31, 2025 | 3,228 | $1.08M | Jan 31, 2025 | Exercise of a Stock Award |
| Erol R. Akdamar Officer | Nov 14, 2024 | 4,872 | $1.74M | Nov 14, 2024 | Exercise of a Stock Award |
| Kathleen M. Whalen Officer | Nov 14, 2024 | 1,474 | $527.68K | Nov 14, 2024 | Exercise of a Stock Award |
| Phillip G. Billington Officer | Nov 14, 2024 | 3,897 | $1.36M | Nov 14, 2024 | Exercise of a Stock Award |
| Michael S. Cuffe Officer | Sep 12, 2024 | 8,358 | $3.22M | Sep 12, 2024 | EXERCISE OF STOCK APPRECIATION RIGHT |
| Kathleen M. Whalen Officer | Jul 31, 2024 | 2,987 | $1.09M | Jul 31, 2024 | Exercise of a Stock Award |